Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted

Journal of Virology

Volumn 75, Issue 9, 2001, Pages 4056-4067

  Guan, Y ^a   Whitney, J B ^a   Detorio, M ^a   Wainberg, M A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; REV PROTEIN;

ANIMAL CELL; ARTICLE; DELETION MUTANT; DNA PACKAGING; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STRUCTURE; RIBOSOME; RNA PROCESSING; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION REGULATION; VIRION; VIRUS MORPHOLOGY; VIRUS MUTANT; VIRUS REPLICATION;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; GENE PRODUCTS, NEF; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; GENE PRODUCTS, VIF; GENE PRODUCTS, VPR; GENES, VIRAL; GENETIC ENGINEERING; GENOME, VIRAL; HUMANS; LEUKOCYTES, MONONUCLEAR; MUTAGENESIS; RNA, VIRAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL REGULATORY PROTEINS;

EID: 0035043279     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.9.4056-4067.2001     Document Type: Article

References (54)

1. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells
2. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques
3. Genetically simpler bovine leukemia virus derivatives can replicate independently of Tax and Rex
4. In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex
5. Why do we not have an HIV vaccine and how can we make one?
6. The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production
7. Infection and replication of Tat- human immunodeficiency viruses: Genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells
8. Vif-negative human immunodeficiency virus type I persistently replicates in primary macrophages, producing attenuated progeny virus
9. A role for mucosal immunity in resistance to HIV infection
10. - human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps
11. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
12. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients
13. Identification of highly attenuated mutants of simian immunodeficiency virus
14. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1
15. HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production
16. Tat as one key to HIV-induced immune pathogenesis and Tat toxoid as an important component of a vaccine
17. Construction and in vitro properties of SIVmac mutants with deletions in nonessential genes
18. Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1
19. Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus
20. Evidence for recombination of live attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain
21. Protective immunity induced by live attenuated simian immunodeficiency virus
22. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: Inverse relationship of degree of protection with level of attenuation
23. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes Nairobi
24. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus
25. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection
26. Fusion-competent vaccines: Broad neutralization of primary isolates of HIV
27. Immunological and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1
28. Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus
29. Lethal neurotoxicity in mice of the basic domains of HIV and SIV Rev proteins: Study of these regions by circular dichroism
30. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection
31. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
32. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons
33. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus
34. The role of nonhuman primates in the development of an AIDS vaccine
35. Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus
36. Molecular pathway involved in HIV-1-induced CNS pathology: Role of viral regulatory protein, Tat
37. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
38. Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed seronegative donors
39. Live attenuated AIDS viruses as vaccines: Promise or peril?
40. Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor
41. Predominance of defective proviral sequences in an HIV+ long-term non-progressor
42. Pelleting virus-infected cells for thin-section electron microscopy
43. Identification and purification of cellular proteins that specifically interact with the RNA constitutive transport elements from retrovirus D
44. A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1
45. Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte inversely correlate with rapid progression to AIDS
46. Persistent infection of rhesus macaques by the Rev-independent Nef(-) simian immunodeficiency virus SIVmac239: Replication kinetics and genomic stability
47. Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions
48. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge
49. Comparison of proviral accessory genes between long-term nonprogressors and progressors of human immunodeficiency virus type 1 infection
50. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: A rationale for the use of Tat toxoid as an HIV-1 vaccine
51. - human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes
52. The requirement of vif of SIVmac is cell-dependent